Arlington Partners LLC Baxter International Inc Transaction History

Arlington Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	BUY	$31.71 - $38.95 $431,541 - $530,070	13,609 New	13,609 $526,000
Q1 2022 Apr 14, 2022	SELL	$76.85 - $89.45 $5,302 - $6,172	-69 Reduced 6.03%	1,076 $83,000
Q4 2021 Jan 18, 2022	SELL	$74.57 - $87.19 $31,692 - $37,055	-425 Reduced 27.07%	1,145 $98,000
Q3 2021 Oct 15, 2021	BUY	$73.77 - $83.61 $113,753 - $128,926	1,542 Added 5507.14%	1,570 $126,000
Q1 2021 Apr 19, 2021	BUY	$76.38 - $86.03 $2,138 - $2,408	28 New	28 $2,000

1,008

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.8B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Arlington Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Arlington Partners LLC with notifications on news.